<?xml version="1.0" encoding="UTF-8"?>
<p>A helpful orientation for guiding clinical processes are the recommendations proposed by the European Society of Cardiology, the American Heart Association/American College of Cardiology, or the 36th Bethesda Conference (2005).
 <sup>24â€“27</sup> Whether this approach is also applicable in COVID-19-associated myocarditis is presently unclear. In any case, a careful follow-up of athletes recovering from the current COVID-19 should be performed. As patients with COVID-19 have been reported to develop cardiovascular complications even in the absence of underlying cardiovascular disease, prospective data collection via registries such as CAPACITY-COVID
 <sup>28</sup> appears to be an important approach.
</p>
